News | Barco celebrates leadership in visionary innovation with Frost & Sullivan Award for medical displays | Barco

Barco understood there was a need for a new generation of diagnostic displays. A generation that breaks through the technical boundaries of multi-modality integration and unifies the entire diagnostic imaging workflow. That’s exactly what the company set out to achieve when it introduced the Coronis Uniti^TM display system in 2014.

A revolution in the reading room
“Coronis Uniti^TM is an evolutionary platform, a universal imaging display system that can support every type of procedure across imaging modalities,” comments David Frigstad, Frost & Sullivan’s Chairman. “The product reflects a visionary understanding of the future which is why Frost & Sullivan decided to recognize Barco as the Visionary Innovation Leader in the global medical imaging displays market.”

Coronis Uniti is the only display that can support PACS as well as multi-modality breast imaging (i.e. 3D mammography, digital mammography, breast MRI and ultrasound) on a single screen, which makes it the perfect alternative to multi-monitor workstation configurations and eliminates the need to change workstations to complete patient studies. Its 33-inch screen with 12 MegaPixel resolution renders high-quality grayscales as well as color and fused modalities, in 2D and 3D, static and dynamic.

“With Coronis Uniti, we set out to change the radiology reading room,” says Lynda Domogalla, Barco’s VP Product Marketing for Healthcare. “It delivers the first unified workflow – combining PACS and breast images on one workstation – to improve workflow efficiency and reading productivity. And it provides radiologists with the best reading experience and viewing comfort thanks to a well thought-through design armed with a world-class feature set.”

Contributing to industry advances
“Coronis Uniti has the potential to elevate a healthcare organization’s diagnostic viewing environment and contribute actively to meeting many of the high-level objectives sought by these organizations, such as enabling earlier detection of pathologies, gaining more confidence in final diagnoses, and reducing the rate of patient recalls,” Chairman Frigstad concludes.

Frost & Sullivan also applauded Barco for its significant contributions to the educational and lobbying efforts necessary to advance the regulatory environment and the clinical adoption curve. In the case of Coronis Uniti, Barco has been actively participating in the industry efforts to establish standards for the use of color in medical imaging and has been taking a leadership role in defining the color standard display function (CDSF).

About Barco
Barco, a global technology company, designs and develops networked visualization products for the Entertainment, Enterprise and Healthcare markets. Barco has its own facilities for Sales & Marketing, Customer Support, R&D and Manufacturing in Europe, North America and APAC. Barco (NYSE Euronext Brussels: BAR) is active in more than 90 countries with 3,300 employees worldwide. Barco posted sales of 1.051 billion euro in 2014.